Dr. Elirehema Mfinanga is an experienced public health physician with over 13 years of expertise in patient care; safety monitoring of medicines and vaccines; clinical development of vaccines and regulatory affairs. Currently serving as the national coordinator for the safety monitoring of vaccines and medicines at the Tanzania Medicines and Medical Devices Authority (TMDA). Dr. Mfinanga plays a crucial role in ensuring the safety and efficacy of medications and vaccines in Tanzania.

In his capacity as the national coordinator, Dr. Mfinanga is responsible for planning and coordinating all activities related to the safety monitoring of medicines and vaccines in Tanzania’s Mainland. He brings extensive knowledge and experience in developing pharmacovigilance systems, particularly tailored for the unique needs of developing countries. His expertise includes developing pharmacovigilance systems; assessment of Periodic Safety Update Reports (PSUR); Risk Management Plans (RMPs), Post-Authorization Safety Studies, and Pharmacovigilance Planning and Causality Assessment.

Driven by a deep passion for improved health outcomes, Dr. Mfinanga strives to make significant contributions to the advancement of health systems, leading to better health outcomes for communities in Tanzania and beyond. He holds a medical doctor’s degree from Muhimbili University of Health and Allied Sciences (MUHAS) and a MSC degree in Vaccinology and Pharmaceutical Clinical Development from Siena University in Italy.

With his diverse expertise and dedication to public health, Dr. Elirehema Mfinanga is at the forefront of ensuring the safety and efficacy of medicines and vaccines in Tanzania.